New test will aid in malaria research

July 17, 2019

New test will aid in malaria research

For more than 100 years, researchers have been looking at blood smears through a microscope to diagnose malaria. A new biomarker test for malaria infection, developed by UW Medicine reseachers and their colleagues, has now been qualified by the FDA for use in certain types of clinical trials. 

Sean Murphy, associate professor of laboratory medicine, explains how the biomarker outperforms the older test and detects blood infections sooner, and what this means for human studies of new drug and vaccine candidates against malaria.

Please see related news release.


Terms of appropriate usage of file downloads

  • News reporters and news organizations may freely republish and distribute videos, still images and audio files produced by UW Medicine and the University of Washington School of Medicine.
  • Works must be attributed/credited appropriately (for example, “UW Medicine” – as denoted in the file) and must not be used for commercial purposes.
  • These visual and audio files may not be used to exploit or misrepresent UW Medicine or the University of Washington.
  • UW Medicine often licenses still images and stock video from Getty Images, but we cannot grant republishing rights. You may not republish single image files, videos or animations credited to Getty Images.
  • Logos of UW Medicine and University of Washington Health Sciences schools may not be republished without explicit permission. Contact us by phone or email: 206.543.3620 or